T. Rowe Price Investment Management, Inc.
Position in ALKS — Alkermes plc.
CIK 1897612
BALTIMORE, MD
Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,165,622
+$25,544,023 QoQ
Shares Held
1,090,947
+22.0% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#37
of 423 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $764,720,816 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
28,750,719 | $707,555,194 | |
| 2 | ALKS |
Alkermes plc.
This page
|
1,090,947 | $57,165,622 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,165,622 | 1,090,947 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,621,599 | 894,276 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $58,730 | 2,099 | Shares | Sole | 2026-02-17 | |
| 2022-09-30 | $101,887,502 | 4,562,808 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||